Trial Profile
Long-term Hepatic and Extra-hepatic Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Interferon-free Treatment (LONGHEAD Study)
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Oct 2023
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- Acronyms LONGHEAD
- 04 Mar 2019 Status changed from recruiting to active, no longer recruiting.
- 28 Feb 2017 Planned number of patients changed from 600 to 200.
- 08 Feb 2017 New trial record